Addex Therapeutics Ltd Stock
Stocks
ADXN
CH0029850754
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0422 CHF | -8.26% |
|
-7.86% | -23.83% |
| 06-17 | Swiss stocks - Factors to watch on June 17 | RE |
| 06-15 | Swiss stocks - Factors to watch on June 15 | RE |
| Market Cap | 6.8M 8.42M 7.34M 6.37M 11.94M 795M 12.01M 80.67M 31.27M 391M 31.61M 30.93M 1.36B | P/E 2024 |
0.8x | P/E 2025 | -0.88x |
|---|---|---|---|---|---|
| Enterprise Value | 5.2M 6.43M 5.61M 4.86M 9.12M 607M 9.18M 61.65M 23.89M 299M 24.15M 23.64M 1.04B | EV / Sales 2024 |
5.67x | EV / Sales 2025 | 28.1x |
| Free-Float |
43.94% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Addex Therapeutics Ltd
| 1 day | -8.26% | ||
| 1 week | -7.86% | ||
| Current month | -8.26% | ||
| 1 month | -10.59% | ||
| 3 months | +8.21% | ||
| 6 months | -20.38% | ||
| Current year | -23.83% |
| 1 week | 0.04 |  | 0.05 |
| 1 month | 0.04 | | 0.05 |
| Current year | 0.03 | | 0.06 |
| 1 year | 0.03 | | 0.08 |
| 3 years | 0.03 | | 0.26 |
| 5 years | 0.03 | | 1.63 |
| 10 years | 0.03 | | 4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tim Dyer
CEO | Chief Executive Officer | 58 | 2013-05-31 |
Lénaic Teyssédou
DFI | Director of Finance/CFO | 40 | 2017-05-31 |
Roger Mills
CTO | Chief Tech/Sci/R&D Officer | 69 | 2016-11-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Vincent Lawton
CHM | Chairman | 77 | - |
Tim Dyer
BRD | Director/Board Member | 58 | 2014-12-31 |
Ray Hill
BRD | Director/Board Member | 81 | 2010-05-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03-17 | Other | Founder | 20,218,775 | 9.2469% | ||
| 03-17 | Other | Chairman | 3,009,585 | 1.3764% | ||
| 03-17 | Other | HEAD OF TRANSLATIONAL SCIENCE | 506,765 | 0.2318% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.26% | -7.86% | -27.74% | -60.38% | 8.42M | |
| +0.94% | +1.37% | -10.55% | -4.78% | 43.13B | |
| +3.31% | +5.93% | +310.97% | +532.23% | 34.65B | |
| +2.84% | +2.14% | +9.34% | +45.55% | 30.03B | |
| -1.70% | -7.54% | +8.43% | -21.54% | 28B | |
| -1.90% | -1.56% | +10.24% | +22.81% | 24.45B | |
| -0.14% | +5.86% | - | - | 14.34B | |
| +0.68% | -1.53% | +48.76% | +108.76% | 13.14B | |
| -0.42% | -1.77% | +4.60% | +6.79% | 12.53B | |
| -0.26% | +1.15% | +98.13% | +79.60% | 12.25B | |
| Average | -0.49% | +1.88% | +50.24% | +78.78% | 21.25B | |
| Weighted average by Cap. | +0.68% | +1.27% | +65.53% | +111.24% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 410K 508K 443K 384K 720K 47.91M 724K 4.86M 1.89M 23.58M 1.91M 1.87M 81.89M | 173K 214K 187K 162K 303K 20.2M 305K 2.05M 795K 9.94M 804K 786K 34.52M |
| Net income | 7.06M 8.74M 7.62M 6.61M 12.39M 824M 12.46M 83.7M 32.44M 406M 32.8M 32.09M 1.41B | -6.73M -8.33M -7.26M -6.3M -11.81M -786M -11.88M -79.82M -30.93M -387M -31.28M -30.61M -1.34B |
| Net Debt | -3.3M -4.09M -3.56M -3.09M -5.79M -386M -5.83M -39.15M -15.17M -190M -15.34M -15.01M -659M | -1.6M -1.99M -1.73M -1.5M -2.82M -187M -2.83M -19.03M -7.37M -92.25M -7.46M -7.3M -320M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-22 | 0.0422 CHF | -8.26% | 21,293 |
| 26-06-19 | 0.0460 CHF | +3.60% | 7,967 |
| 26-06-18 | 0.0444 CHF | +1.37% | 72,001 |
| 26-06-17 | 0.0438 CHF | +0.46% | 266,435 |
| 26-06-16 | 0.0436 CHF | -4.80% | 593,144 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ADXN Stock
Select your edition
All financial news and data tailored to specific country editions
